Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia

The treatment (i.e. therapy and management) of chronic lymphocytic leukemia (i.e. the disease) has been improved thanks to the introduction (i.e. approval) of kinase inhibitors during the last years. PI3K is one of the most important kinases at the crossroad to the B-cell receptor and cytokine recep...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Onco Targets Ther
Autors principals: Visentin, Andrea, Frezzato, Federica, Severin, Filippo, Imbergamo, Silvia, Pravato, Stefano, Romano Gargarella, Leila, Manni, Sabrina, Pizzo, Serena, Ruggieri, Edoardo, Facco, Monica, Brunati, Anna Maria, Semenzato, Gianpietro, Piazza, Francesco, Trentin, Livio
Format: Artigo
Idioma:Inglês
Publicat: Dove 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7532889/
https://ncbi.nlm.nih.gov/pubmed/33061448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S268899
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars